作者:Aeglea生物制药(AGLE)
发布于: | 公告 | 转发:0 | 回复:0 | 喜欢:0 |
$Aeglea BioTherapeutics, Inc.(AGLE)$ 8-K - Current report Filed: 2017-11-07 AccNo: 0001564590-17-022245 Size: 293 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接